Inventor
KLASSEN PRESTON
US11 patents
⚠️ This page may combine multiple inventors who share the name “KLASSEN PRESTON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
OREXIGEN THERAPEUTICS INC
4 patentsUS9119850B2Sep 1, 2015
Compositions and methods for weight loss in at risk patient populations
OREXIGEN THERAPEUTICS INC15 citations92
US8969371B1Mar 3, 2015
Compositions and methods for weight loss in at risk patient populations
OREXIGEN THERAPEUTICS INC18 citations92
US9801875B2Oct 31, 2017
Compositions and methods for weight loss in at risk patient populations
OREXIGEN THERAPEUTICS INC8 citations83
US9633575B2Apr 25, 2017
Methods of treating overweight and obesity
OREXIGEN THERAPEUTICS INC9 citations83
NALPROPION PHARMACEUTICALS LLC
4 patentsUS11998542B2Jun 4, 2024
Compositions and methods for reducing major adverse cardiovascular events
NALPROPION PHARMACEUTICALS LLC3 citations84
US10835527B2Nov 17, 2020
Compositions and methods for reducing major adverse cardiovascular events
NALPROPION PHARMACEUTICALS LLC6 citations83
US10828294B2Nov 10, 2020
Compositions and methods for weight loss in at risk patient populations
NALPROPION PHARMACEUTICALS LLC6 citations83
US11139056B2Oct 5, 2021
Methods of treating overweight and obesity
NALPROPION PHARMACEUTICALS LLC4 citations72
NALPROPION PHARMACEUTICALS INC
3 patentsUS10231964B2Mar 19, 2019
Compositions and methods for weight loss in at risk patient populations
NALPROPION PHARMACEUTICALS INC8 citations91
US10403170B2Sep 3, 2019
Methods of treating overweight and obesity
NALPROPION PHARMACEUTICALS INC6 citations82
US10231962B2Mar 19, 2019
Compositions and methods for reducing major adverse cardiovascular events
NALPROPION PHARMACEUTICALS INC5 citations82